88
Participants
Start Date
August 8, 2019
Primary Completion Date
February 1, 2024
Study Completion Date
February 1, 2024
Medically-supervised withdrawal
6-8 day withdrawal with buprenorphine/naloxone
Opioid agonist treatment
Induction and maintenance with buprenorphine/naloxone
Comprehensive clinical care
Obstetrical visits, counseling, case management, psychiatry services, and urine drug screening
Virginia Commonwealth University, Richmond
UNC Chapel Hill Horizons, Chapel Hill
Mountain Area Health Education Center, Asheville
University of Vermont, Burlington
University of North Carolina, Chapel Hill
OTHER
Virginia Commonwealth University
OTHER
Mountain Area Health Education Center
UNKNOWN
Johns Hopkins University
OTHER
National Institute on Drug Abuse (NIDA)
NIH
University of Vermont
OTHER